Pulak R Nath

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Venues

Nature communications

Cancer immunology, immunotherapy : CII

National Institutes of Health

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Institutes of Health Jun 23 2019

United States

Staff Scientist :: Laboratory of Immunology

Jackson Laboratory - Farmington May 14 2018 - Jun 22 2019

United States

Postdoc Associate :: Immunology

National Cancer Institute

United States

Visiting Fellow :: Pathology

Publications

Pulak R Nath, Mary Maclean, Vijayaraj Nagarajan, Jung Wha Lee, Mehmet Yakin, Aman Kumar, Hadi Nadali, Brian Schmidt, Koray D Kaya, Shilpa Kodati, Alice Young, Rachel R Caspi, Jonas J W Kuiper, H Nida Sen
Single-cell profiling identifies a CD8 bright CD244 bright Natural Killer cell subset that reflects disease activity in HLA-A29-positive birdshot chorioretinopathy. Nature communications 15 (1) (2024)
Pulak R Nath, Mary Maclean, Vijayaraj Nagarajan, Jung Wha Lee, Mehmet Yakin, Aman Kumar, Hadi Nadali, Brian Schmidt, Koray D Kaya, Shilpa Kodati, Alice Young, Rachel R Caspi, Jonas J W Kuiper, H Nida Sen
Single-cell profiling identifies a CD8 bright CD244 bright Natural Killer cell subset that reflects disease activity in HLA-A29-positive birdshot chorioretinopathy. Nature communications 15 (1) (2024)
Pulak R Nath, Mary Maclean, Vijayaraj Nagarajan, Jung Wha Lee, Mehmet Yakin, Aman Kumar, Hadi Nadali, Brian Schmidt, Koray D Kaya, Shilpa Kodati, Alice Young, Rachel R Caspi, Jonas J W Kuiper, H Nida Sen
Single-cell profiling identifies a CD8 bright CD244 bright Natural Killer cell subset that reflects disease activity in HLA-A29-positive birdshot chorioretinopathy. Nature communications 15 (1) (2024)
Anthony L Schwartz, Pulak R Nath, Michael Allgauer, Elizabeth C Lessey-Morillon, John M Sipes, Lisa A Ridnour, Y Maurice Morillon Ii, Zhiya Yu, Nicholas P Restifo, David D Roberts
Antisense targeting of CD47 enhances human cytotoxic T-cell activity and increases survival of mice bearing B16 melanoma when combined with anti-CTLA4 and tumor irradiation. Cancer immunology, immunotherapy : CII 68 (11) (2019)

Pulak R Nath.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pulak R Nath